|Articles|May 31, 2020

ASCRS 2020: Evolution of an administration technique for DEXYCU

Ophthalmology Times' David Hutton speaks with Michael Saidel, MD, a cornea and cataract specialist, on his presentation regarding "Evolution of an administration technique for DEXYCU (dexamethasone intraocular suspension) 9%" during the 2020 ASCRS virtual meeting.
 

See more ASCRS coverage here 

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.


Latest CME